| CEO: | Peter Collins |
| Executive Chairman: | Jan Groen |
| Senior Independent Director: | Klaas de Boer |
| Non-Executive Dir: | Benjamin Hart , Kim Oreskovic |
| Address: | 10 Nugent Road, Surrey Research Park, Guildford, Surrey, United Kingdom, GU2 7AF |
| Phone: | +44 (0)1483 343434 |
| Website: | http://cellbxhealth.com |
| Sector: | Support(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0034330679 |
| Currency | UK Pounds |
| Share Price | 0.60p |
| Change Today | -0.025p |
| % Change | -4.00 % |
| 52 Week High | 2.65 |
| 52 Week Low | 0.55 |
| Volume | 2,061,906 |
| Shares Issued | 1,139.40m |
| Market Cap | £6.84m |
| Beta | 0.02 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:16 | 100,000 @ 0.63p |
| 14:55 | 250,000 @ 0.63p |
| 12:16 | 157,472 @ 0.63p |
| 11:57 | 8,012 @ 0.62p |
| 11:04 | 79,544 @ 0.57p |
You are here: research